05-13-2022, 11:02 PM
Supply chain issues and a lack of market competition (the company that owns Similac, one of the largest producers in the US, has shut down plants following a fatal contamination outbreak months ago) led to the shortage. Basically, a company was scared of law suits so they stopped production.
The US is sending $40 billion to Ukraine. That's unrelated to US companies being crappy and ill prepared and enjoying a structure which doesn't support competition. The current administration didn't do anything to encourage a practical monopoly on the formula market. If anything, it's trying to help out a capitalistic fail as the FDA is expediting reviews of foreign formulas being imported and permits.
I mean, sure, I guess the government could take total control over the formula industry to make sure the manufacturing doesn't take a dip. But is that the direction anyone wants to go?
The US is sending $40 billion to Ukraine. That's unrelated to US companies being crappy and ill prepared and enjoying a structure which doesn't support competition. The current administration didn't do anything to encourage a practical monopoly on the formula market. If anything, it's trying to help out a capitalistic fail as the FDA is expediting reviews of foreign formulas being imported and permits.
I mean, sure, I guess the government could take total control over the formula industry to make sure the manufacturing doesn't take a dip. But is that the direction anyone wants to go?